Antiparasitic Therapy Course

Lesson 1 • Epidemiology of Parasitic Infections

Analyses global burden, geographic distribution, and risk populations for major parasitic diseases. Contextualises treatment priorities and public health impact.

Lesson 2 • Host-Parasite Interaction Basics

Examines how parasites evade host immunity and establish infection. These mechanisms explain why certain drug classes are required.

Lesson 3 • Pathophysiology of Parasitic Disease

Describes tissue damage, inflammatory responses, and organ-specific effects caused by parasites. Links pathology to clinical presentation and treatment goals.

Lesson 4 • Parasite Life Cycles and Transmission

Explains direct and indirect life cycles, definitive and intermediate hosts. Understanding transmission routes underpins rational drug targeting.

Lesson 1 • Pharmacokinetics of Antiparasitic Drugs

Analyses absorption, distribution, metabolism, and excretion profiles specific to antiparasitic agents. Explains how PK properties determine dosing regimens.

Lesson 2 • Drug Interactions and Adverse Effects

Catalogues clinically significant interactions and toxicity profiles of major antiparasitic classes. Prepares students to anticipate and manage adverse outcomes.

Lesson 3 • Mechanisms of Anthelmintic Drugs

Explains neuromuscular blockade, tubulin disruption, and ion channel modulation used against helminths. Differentiates mechanisms across nematodes, cestodes, and trematodes.

Lesson 4 • Drug Target Identification in Parasites

Identifies unique parasite biochemical targets exploited by antiparasitic drugs. Establishes the rationale for selective toxicity over host cells.

Lesson 1 • Imaging and Ancillary Investigations

Describes the role of ultrasound, CT, MRI, and laboratory panels in parasitic disease workup. Integrates imaging findings with clinical and microbiological data.

Lesson 2 • Microscopic Diagnostic Techniques

Teaches preparation and interpretation of blood films, stool smears, and tissue specimens. Microscopy remains the gold standard for many parasitic diagnoses.

Lesson 3 • Serological and Molecular Diagnostics

Covers antibody detection, antigen tests, and PCR-based methods for parasitic infections. Explains sensitivity, specificity, and appropriate test selection.

Lesson 4 • Differential Diagnosis Frameworks

Applies systematic frameworks to distinguish parasitic from non-parasitic causes of common syndromes. Reduces diagnostic error in complex presentations.

Lesson 1 • Leishmaniasis Treatment Strategies

Addresses cutaneous, mucocutaneous, and visceral leishmaniasis with appropriate drug selection. Emphasises liposomal amphotericin B and miltefosine indications.

Lesson 2 • Opportunistic Protozoa in Immunocompromised Hosts

Focuses on toxoplasmosis, microsporidiosis, and Pneumocystis in immunocompromised patients. Integrates treatment with prophylaxis and immune reconstitution considerations.

Lesson 3 • Trypanosomiasis Management

Covers African sleeping sickness and Chagas disease with stage-specific drug regimens. Distinguishes early vs. late-stage treatment approaches.

Lesson 4 • Intestinal Protozoa Treatment

Provides treatment protocols for giardiasis, cryptosporidiosis, amoebiasis, and cyclosporiasis. Addresses luminal vs. tissue-active drug selection.

Lesson 1 • Tissue Nematode Infections

Addresses treatment of filariasis, trichinellosis, toxocariasis, and cutaneous larva migrans. Highlights diethylcarbamazine and ivermectin indications.

Lesson 2 • Anthelmintic Therapy in Special Populations

Adapts helminth treatment for pregnancy, paediatrics, and organ-impaired patients. Addresses safety data gaps and risk-benefit decision-making.

Lesson 3 • Trematode Infections Treatment

Provides praziquantel-based protocols for schistosomiasis, liver flukes, and lung flukes. Explains dose variation by species and infection site.

Lesson 4 • Cestode Infections and Cystic Disease

Covers taeniasis, neurocysticercosis, and echinococcosis with albendazole and praziquantel protocols. Integrates surgical and medical management decisions.

Lesson 1 • Anthelmintic Resistance Patterns

Examines benzimidazole and macrocyclic lactone resistance in helminths, primarily in veterinary-to-human spillover contexts. Addresses detection methods.

Lesson 2 • Strategies to Contain Resistance

Presents combination therapy, drug rotation, and stewardship principles to slow resistance emergence. Applies lessons from antimicrobial stewardship to antiparasitic practice.

Lesson 3 • Mechanisms of Resistance Development

Explains genetic mutations, efflux pumps, and metabolic bypass routes that confer resistance. Connects molecular mechanisms to clinical treatment failure.

Lesson 4 • Detecting and Monitoring Resistance

Covers in vitro assays, molecular surveillance, and clinical failure criteria for resistance detection. Enables practitioners to recognise and report resistance.

Lesson 1 • Managing Treatment Failure

Defines treatment failure criteria, investigates causes, and outlines salvage regimens. Distinguishes true failure from reinfection and non-adherence.

Lesson 2 • Parasitic Infections During Pregnancy

Evaluates teratogenicity, placental transmission, and maternal-fetal risk for each drug class. Provides trimester-specific treatment guidance.

Lesson 3 • Parasitic Infections in HIV Patients

Addresses altered disease presentation, drug interactions with antiretrovirals, and immune reconstitution inflammatory syndrome. Integrates HIV management with antiparasitic therapy.

Lesson 4 • Paediatric Antiparasitic Therapy

Adapts adult protocols to paediatric pharmacokinetics, formulation availability, and age-specific dosing. Addresses off-label use and weight-based calculations.

Lesson 1 • Chemoprophylaxis for Travellers

Covers malaria prophylaxis drug selection, timing, and duration for travellers to endemic regions. Addresses contraindications and adherence counselling.

Lesson 2 • Vaccines and Emerging Preventive Tools

Reviews approved and pipeline vaccines for malaria and other parasitic diseases. Positions vaccines within integrated prevention frameworks.

Lesson 3 • Mass Drug Administration Programmes

Explains the rationale, logistics, and outcomes of population-level deworming and filariasis elimination programmes. Addresses coverage targets and adverse event monitoring.

Lesson 4 • Vector and Environmental Control

Describes insecticide-treated nets, indoor residual spraying, and water sanitation as parasite control tools. Complements drug-based strategies with environmental interventions.